This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep;5(9):1315-9.

doi: 10.2217/fmb.10.99.

Azithromycin paradox in the treatment of cystic fibrosis airway disease

Christopher D Sibley¹, Margot E Grinwis, Harvey R Rabin, Michael G Surette

Affiliations

PMID: 20860478
DOI: 10.2217/fmb.10.99

Comment

Azithromycin paradox in the treatment of cystic fibrosis airway disease

Christopher D Sibley et al. Future Microbiol. 2010 Sep.

. 2010 Sep;5(9):1315-9.

doi: 10.2217/fmb.10.99.

Authors

Christopher D Sibley¹, Margot E Grinwis, Harvey R Rabin, Michael G Surette

Affiliation

¹ Department of Microbiology & Infectious Diseases, University of Calgary, Alberta, Canada.

PMID: 20860478
DOI: 10.2217/fmb.10.99

No abstract available

PubMed Disclaimer

Comment on

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F; AZ0004 Azithromycin Study Group. Saiman L, et al. JAMA. 2010 May 5;303(17):1707-15. doi: 10.1001/jama.2010.563. JAMA. 2010. PMID: 20442386 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.